Home / Business and Economy / Pharma Surges: Bulls Eye Breakout, Metal Dives
Pharma Surges: Bulls Eye Breakout, Metal Dives
22 Jun
Summary
- Nifty Pharma nears trendline breakout with strong derivatives support.
- Nifty Metal shows persistent weakness, facing wedge formation resistance.
- FIIs increased long positions, reducing short contracts significantly.
The past week concluded with subdued market activity, influenced by fluctuating hopes of a US-Iran ceasefire deal. Despite an initial downturn on Friday, a notable recovery by bulls maintained a constructive market structure. This resilience is underscored by a significant percentage of Nifty 500 constituents closing above their 10-day moving average.
Foreign Institutional Investors notably increased their long positions in the Index Future segment, reducing short holdings and signaling a more optimistic outlook. This shift in sentiment provides a supportive backdrop for potential market upside.
Within this environment, the Nifty Pharma index is exhibiting promising signs of a bullish turnaround. Technical indicators suggest an imminent trendline breakout, supported by positive derivatives data indicating increased long buildup and short covering among traders.
Conversely, the Nifty Metal index is demonstrating continued weakness, having failed to sustain gains at a key resistance level. Technical indicators, including a bearish MACD crossover, point towards potential further declines, with immediate support identified at the 12,400 level.
Sector-specific analysis reveals that heavyweights in the pharmaceutical sector, such as Biocon and Sun Pharmaceutical Industries, are showing signs of accumulation and are expected to propel the Nifty Pharma index higher. In contrast, the Nifty Metal index faces downward pressure, with market participants betting on limited upside or further depreciation.
